Evidence map›Paper›PMID 41945239›Full record

ArticleInsights into imaging2026

Strategies for sustainable lung cancer screening: a multi-faceted perspective to long-term surveillance in SOLACE.

Emily Nischwitz, Roberta Eufrasia Ledda, Tom Stargardt, Carsten Wältner, Katarzyna Sejbuk-Rozbicka, Joanna Bidzinska, Joanna Moes-Sosnowska, Joanna Chorostowska-Wynimko, Mathis Konrad, Elizabeth Tong and 5 more

Abstract read
In one paragraph

Article in Insights into imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Emily NischwitzDepartment of Diagnostic and Interventional Radiology (DIR), Heidelberg University Hospital, Heidelberg, Germany.
Roberta Eufrasia LeddaDepartment of Medicine and Surgery, University of Parma, Parma, Italy.
Tom StargardtHamburg Center for Health Economics (HCHE), University of Hamburg, Hamburg, Germany.
Carsten WältnerHamburg Center for Health Economics (HCHE), University of Hamburg, Hamburg, Germany.
Katarzyna Sejbuk-RozbickaLazarski University, Warsaw, Poland.
Joanna BidzinskaSecond Department of Radiology, Medical University of Gdansk, Gdańsk, Poland.
Joanna Moes-SosnowskaDepartment of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.
Joanna Chorostowska-WynimkoDepartment of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.
Mathis KonradDepartment of Diagnostic and Interventional Radiology (DIR), Heidelberg University Hospital, Heidelberg, Germany.
Elizabeth TongDepartment of Diagnostic and Interventional Radiology (DIR), Heidelberg University Hospital, Heidelberg, Germany.
Małgorzata Gałazka-SobotkaLazarski University, Warsaw, Poland.
Edyta SzurowskaSecond Department of Radiology, Medical University of Gdansk, Gdańsk, Poland.
Dominik R DziurdaLazarski University, Warsaw, Poland.
Hans-Ulrich KauczorDepartment of Diagnostic and Interventional Radiology (DIR), Heidelberg University Hospital, Heidelberg, Germany.
Viktoria PalmDepartment of Diagnostic and Interventional Radiology (DIR), Heidelberg University Hospital, Heidelberg, Germany. viktoria.palm@med.uni-heidelberg.de.ORCID http://orcid.org/0000-0002-4369-6752

Funding

EU4Health Programme 2021-2027 101101187
6 · The paper itself

Abstract

Lung cancer is the leading cause of cancer-related deaths globally. To detect lung cancer at an earlier, treatable stage, low-dose chest CT is a critical tool for risk-based lung cancer screening. With the growing large-scale, multidisciplinary support for the implementation of lung cancer screening, it is important to ensure these programmes are implemented in a sustainable and effective manner. This review focuses on the three fundamental dimensions of sustainability: ecological, social, and economic. It examines strategies for their effective implementation in accordance with current best practices. Ecological sustainability involves reducing energy use and emissions and leveraging technological innovations to positively impact the environment. Economic sustainability highlights the need to evaluate long-term financial capacity and infrastructure and the role of effective risk-stratification. Social sustainability centres on equitable access to lung cancer screening programmes, particularly for currently underserved populations, with a focus on targeted recruitment strategies. We present an overview of current challenges, an analysis of best practices, and examples of real-world implementation, with a particular emphasis on initiatives in the SOLACE project. CLINICAL RELEVANCE STATEMENT: This review highlights the importance of a multidisciplinary and sustainable approach to implementing lung cancer screening by integrating ecological, economic and social sustainability practices. KEY POINTS: Lung cancer screening requires balanced consideration of all three sustainability pillars: ecological, economic, and social. This review examines sustainability practices in lung cancer screening, highlighting use cases from SOLACE and beyond. Lung cancer screening must embed all aspects of sustainability to achieve lasting clinical and social impact.

Indexed as

Ecological sustainabilityEconomic sustainabilityLung cancer screeningSOLACESustainability

Identifiers

PMID41945239
PMCPMC13057096

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.